The Medipattern Corporation V.MKI

GE buyout

[mvreno]

Visualize:Vascular™ is not the only product Medipattern has in their pipeline. Their Cadenza™ Platform received extended patent protection for kinetic studies and combining imaging techniques. This patent solidified Medipattern's position as a globally recognized leading edge developer of medical imaging analysis tools. MKI has used the Cadenza™ algorithm platform to collaborate with GE Healthcare in order create Ultrasound-based Vascular Imaging Quantification Tools, aiding in the analysis of vascular disease and improving the speed and accuracy of diagnoses. Medipattern's relationship with such a large health care partner creates the possibility of it being a potential buyout target by that partner, especially since MKI has successfully launched another product in their pipeline.

found this blurb in tsxnews site. great possibility now that the news is out the company is turning profit,
cheap purchase from GE if they are interested